Does CAMRELIZUMAB Cause Hepatic encephalopathy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatic encephalopathy have been filed in association with CAMRELIZUMAB. This represents 1.2% of all adverse event reports for CAMRELIZUMAB.
5
Reports of Hepatic encephalopathy with CAMRELIZUMAB
1.2%
of all CAMRELIZUMAB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Hepatic encephalopathy From CAMRELIZUMAB?
Of the 5 reports, 1 (20.0%) resulted in death, 3 (60.0%) required hospitalization.
Is Hepatic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAMRELIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CAMRELIZUMAB Cause?
Myelosuppression (70)
Fatigue (60)
Nausea (60)
Vomiting (59)
Diarrhoea (54)
Anaemia (53)
Hypothyroidism (53)
Off label use (52)
Rash (50)
Thrombocytopenia (46)
What Other Drugs Cause Hepatic encephalopathy?
ACETAMINOPHEN (562)
RIBAVIRIN (512)
LENVATINIB (502)
RIFAXIMIN (462)
SOFOSBUVIR (360)
BEVACIZUMAB (210)
LEDIPASVIR\SOFOSBUVIR (180)
ATEZOLIZUMAB (178)
SORAFENIB (169)
DACLATASVIR (165)
Which CAMRELIZUMAB Alternatives Have Lower Hepatic encephalopathy Risk?
CAMRELIZUMAB vs CANAGLIFLOZIN
CAMRELIZUMAB vs CANAGLIFLOZIN\METFORMIN
CAMRELIZUMAB vs CANAKINUMAB
CAMRELIZUMAB vs CANDESARTAN
CAMRELIZUMAB vs CANDESARTAN CILEXETIL